Weill Cornell Medicine Events

Development of Xofluza: The First New Class of Influenza Drugs in 20 Years

Special Pharmacology Seminar

Mark D. Eisner, M.D., M.P.H.
Senior Vice President, Product Development
Immunology, Infectious Disease 
and Opthalmology
Genentech, Inc., San Francisco, California

Host: Dr. Lorraine J. Gudas

Coffee and cookies: 12:40 p.m.

Thursday, April 25 at 1:00pm to 2:00pm


Weill Auditorium
1300 York Ave New York, NY 10065

Event Type

Lecture/Seminar, Basic Science Lecture/Seminar, Clinical Lecture/Seminar, Information Session

Departments

Pharmacology

Mission

Education, Research

Website

http://www.cornellpharmacology.org/

Subscribe
Google Calendar iCal Outlook

Recent Activity